Dosimetric advantages of daily adaptive strategy in IMPT for high-risk prostate cancer.
Tamura H, Kobashi K, Nishioka K, Yoshimura T, Hashimoto T, Shimizu S, Ito YM, Maeda Y, Sasaki M, Yamamoto K, Tamamura H, Aoyama H, Shirato H.
Tamura H, et al. Among authors: sasaki m.
J Appl Clin Med Phys. 2022 Apr;23(4):e13531. doi: 10.1002/acm2.13531. Epub 2022 Jan 19.
J Appl Clin Med Phys. 2022.
PMID: 35045211
Free PMC article.